Sailaja Puttagunta
Chief Tech/Sci/R&D Officer presso ITERUM THERAPEUTICS PLC
Patrimonio netto: 15 968 $ in data 31/03/2024
Profilo
Sailaja Puttagunta is currently the Chief Medical Officer at Iterum Therapeutics Plc.
She previously held positions as Vice President of Development & Medical Affairs at Durata Therapeutics, Vice President of Medical Affairs at Allergan Ltd., Vice President of Development at Iterum Therapeutics Plc, and Chief Medical Officer at BiomX Ltd.
and BiomX, Inc. She received her graduate degree from New York University School of Medicine and her undergraduate degree from Gandhi Medical College & Hospital.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
ITERUM THERAPEUTICS PLC
0.08% | 01/12/2023 | 10 369 ( 0.08% ) | 15 968 $ | 31/03/2024 |
Posizioni attive di Sailaja Puttagunta
| Società | Posizione | Inizio |
|---|---|---|
| ITERUM THERAPEUTICS PLC | Chief Tech/Sci/R&D Officer | 13/12/2021 |
Precedenti posizioni note di Sailaja Puttagunta
| Società | Posizione | Fine |
|---|---|---|
| BIOMX INC. | Chief Tech/Sci/R&D Officer | 13/12/2021 |
BiomX Ltd.
 BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | Chief Tech/Sci/R&D Officer | 01/10/2019 |
| ITERUM THERAPEUTICS PLC | Corporate Officer/Principal | 01/12/2018 |
| ALLERGAN PLC | Chief Tech/Sci/R&D Officer | 01/01/2016 |
| DURATA THERAPEUTICS INC | Chief Tech/Sci/R&D Officer | 01/12/2014 |
Formazione di Sailaja Puttagunta
| Gandhi Medical College & Hospital | Undergraduate Degree |
| New York University School of Medicine | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| ITERUM THERAPEUTICS PLC | Health Technology |
| BIOMX INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Allergan Ltd. (Ireland)
 Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland. | Health Technology |
BiomX Ltd.
BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | Health Technology |
Durata Therapeutics, Inc.
 Durata Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Durata Therapeutics, Inc. develops and commercializes novel therapeutics for infectious diseases and acute illnesses. The company was founded on November 4, 2009 and is headquartered in Chicago, IL. | Health Technology |
- Borsa valori
- Insiders
- Sailaja Puttagunta
